Journal of wound care最新文献

{"title":"Use of cadaveric skin allograft and Integra Dermal Regeneration Template to manage deep lower limb injuries.","authors":"Gustavo E Prezzavento, Lucila M Olivera Whyte, Rodrigo N Juárez Calvi, Juan A Rodríguez, Philippe Taupin","doi":"10.12968/jowc.2023.0230","DOIUrl":"https://doi.org/10.12968/jowc.2023.0230","url":null,"abstract":"<p><strong>Objective: </strong>In full-thickness wounds, it is necessary to have an appropriate dermal replacement because dermal tissue does not regenerate into normal dermis after injury. The use of a dermal matrix underneath a skin graft during the healing process provides a scaffold that supports tissue growth, resulting in improvement of cosmesis and functional outcomes. The management of large wounds with deep skin impairment using a combination of dermal matrices has not been exhaustively studied. The objective of this study was to evaluate the results of managing lower limb trauma, with deep skin impairment, by combining the use of dermal matrices in stages.</p><p><strong>Method: </strong>This was a retrospective study of patients with lower limb trauma managed using a combination of cadaveric skin and Integra Dermal Regeneration Template (IDRT; Integra LifeSciences Corp., US) in stages, followed by an autologous skin graft, in the Hospital Aleman, Buenos Aires, Argentina from 2014-2021. Cosmesis was evaluated with the Vancouver Scar Scale (VSS) and Patient and Observer Scar Assessment Scale (POSAS). Functional outcomes were assessed one year after surgery.</p><p><strong>Results: </strong>In total, five patients were treated. The average affected body surface area was 11.2%. The average cadaveric skin, IDRT and skin autograft take rates were 98.4%, 98.4% and 99%, respectively. Upon follow-up, six months after surgery, the mean VSS was 3.2 and the mean POSAS was 27.8. After 12 months, the mean VSS was 2.6 and the mean POSAS was 22.6. In addition, no depression of the covered surfaces was observed. All patients recovered full articular function and movement after physical therapy.</p><p><strong>Conclusion: </strong>All patients presented full wound coverage with satisfactory cosmesis and functional outcomes. The combination of the use of cadaveric skin and IDRT consecutively in the same wound bed provides promising results for the management of lower limb trauma wounds with deep skin impairment.</p>","PeriodicalId":17590,"journal":{"name":"Journal of wound care","volume":"34 3","pages":"239-248"},"PeriodicalIF":1.5,"publicationDate":"2025-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143567555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Chemotherapy-induced leg ulcers: a case series.","authors":"Marion Rousselot, Emmanuel Mahé, Patricia Senet, Philippe Rousselot, Nathalie Baudot, Sandra Moawad, Amélie Schoeffler, Elisa Goujon, Béatrice Villemur, Catherine Lok, Jean-François Cuny, Aurore Le Guern, Michèle-Léa Sigal, Emilie Tella","doi":"10.12968/jowc.2020.0128","DOIUrl":"https://doi.org/10.12968/jowc.2020.0128","url":null,"abstract":"<p><strong>Objective: </strong>New therapeutic classes of chemotherapy, including tyrosine kinase inhibitors (TKIs), are being developed, leading to unexpected cutaneous side-effects. The aim was to analyse the development of leg ulcers (LUs) associated with chemotherapy to identify their characteristics and management.</p><p><strong>Method: </strong>A retrospective multicentre study was conducted across nine French dermatology departments and one haematology department. We collected information on cancer history, cofactors of LUs, and management and evolution of the LUs.</p><p><strong>Results: </strong>The study included 45 patients divided into three groups: hydroxyurea treatment; targeted therapies including TKIs; and taxane treatment. Certain factors were common for arteriovenous leg ulcers, especially advanced age, the frequency of vascular cofactors and the painful nature of the ulcer; however, significant differences were apparent. In particular, the delay between the introduction of chemotherapy and the beginning of the LU. The delay in appearance of the LU was shorter for patients in the taxanes and TKIs groups versus patients treated with hydroxyurea (hydroxyurea versus taxanes: p<0.0001; hydroxyurea versus TKIs: p=0.004). Following the appearance of the LU, treatment was normally stopped (88%), with cicatrisation (91%) occurring within a period of 4.6 months on average. These results confirm the known association of hydroxyurea and LUs; however, other chemotherapies, including targeted therapies and taxanes, appear to be involved.</p><p><strong>Conclusion: </strong>Prescribers should be made aware of skin side-effects of chemotherapies and the risk-benefit of discontinuing chemotherapy for ulcer healing should be raised. Closer monitoring to control identified cofactors of LUs is required in patients receiving this type of chemotherapy, especially if they have LU-predisposing factors.</p>","PeriodicalId":17590,"journal":{"name":"Journal of wound care","volume":"34 3","pages":"250-254"},"PeriodicalIF":1.5,"publicationDate":"2025-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143567448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Advanced wound therapies to promote healing in patients with severe peripheral arterial disease: two case reports.","authors":"Helen Meagher, Shauna Chaplin, Tara Holmes, Michael Anthony Moloney","doi":"10.12968/jowc.2022.0291","DOIUrl":"https://doi.org/10.12968/jowc.2022.0291","url":null,"abstract":"<p><p>Patients with significant peripheral arterial disease (PAD) face many challenges with wound healing. This is primarily due to lack of adequate blood flow to a wound site to allow effective healing. Restoration of adequate blood flow may require surgical as well as medical interventions. Consequently, patients with PAD may have surgical wounds in addition to pre-existing arterial ulcers they have on presentation to a vascular service. A holistic approach to wound assessment and care planning is crucial to optimise healing. This case study outlines the importance of using advanced wound therapies in addition to evidence-based holistic wound care to achieve healing in two patients with complex PAD.</p>","PeriodicalId":17590,"journal":{"name":"Journal of wound care","volume":"34 3","pages":"215-219"},"PeriodicalIF":1.5,"publicationDate":"2025-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143567490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Multidisciplinary approach to squamous cell carcinoma originating in hidradenitis suppurativa lesions: a case report.","authors":"Huining Wang, Zumei Song, Dongyun Xia, Qian Tang, Ling Wu, Lili Yu, Xiaoling Sun","doi":"10.12968/jowc.2023.0200","DOIUrl":"https://doi.org/10.12968/jowc.2023.0200","url":null,"abstract":"<p><p>Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin disease, and squamous cell carcinoma (SCC) is a rare complication of longstanding HS. In this case report, we describe the clinical management of a 30-year-old male patient with HS, with an eight-year history of a recurrent abscess and a nonhealing ulcer-like wound on his right buttock. The patient was also diagnosed with SCC originating from HS. A multidisciplinary team was established, comprising an oncologist, a plastic surgeon and two enterostomal therapists, to administer various treatments including chemotherapy, wound care, and surgical removal of lesions. The wound completely healed 201 days later, without any recurrence observed during follow-up.</p>","PeriodicalId":17590,"journal":{"name":"Journal of wound care","volume":"34 3","pages":"196-199"},"PeriodicalIF":1.5,"publicationDate":"2025-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143567553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Innovative treatment of diabetic ulcers: combining chemical debridement and xenograft applications: a case study.","authors":"William Tettelbach, Nya Akoteu, Katrina-Anne Palu, Emily Walsh, Michelle Moore","doi":"10.12968/jowc.2025.0010","DOIUrl":"https://doi.org/10.12968/jowc.2025.0010","url":null,"abstract":"<p><p>Lower extremity diabetic ulcers (LEDUs) are a common, high-morbidity complication of diabetes, frequently leading to infections, hospitalisations and emergency department visits. This case study examines the treatment effectiveness of a novel wound care approach in a 57-year-old female patient with a hard-to-heal LEDU (a diabetic foot ulcer of the left lower extremity) complicated by poorly controlled diabetes (glycated haemoglobin A1c: 13%). Initially, standard of care (SoC) practices, including alginate dressings, hypochlorous acid gel and sharp debridement, were ineffective in promoting significant healing. This case was further challenged by its occurrence in the remote setting of Tongatopu within the Kingdom of Tonga, where advanced wound care materials and even SoC products are not consistently available, underscoring the need for innovative and adaptable treatment strategies. A new regimen was subsequently initiated that involved preparing the wound bed through chemical debridement using a topical desiccating agent (TDA) with methanesulfonic acid (DEBRICHEM, DEBx Medical, the Netherlands), which has the ability to denature proteins and reduce microbial biofilms, necrotic tissue and inflammatory proteins in the wound bed. This was followed by the application of ovine forestomach matrix (OFM) grafts containing hyaluronic acid (Symphony, Aroa Biosurgery, New Zealand), which was applied at approximately 12-day intervals. Over the 110 days following the initial application of the TDA, the LEDU showed significant improvement as it progressed along the healing cascade towards closure. This case report provides insights into the potential of combined desiccating chemical debridement and xenograft-based wound care in treating hard-to-heal LEDUs, highlighting an approach that could inform future clinical practices in diabetic wound care.</p>","PeriodicalId":17590,"journal":{"name":"Journal of wound care","volume":"34 3","pages":"200-204"},"PeriodicalIF":1.5,"publicationDate":"2025-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143567549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical outcomes of lyophilised human amnion/chorion membrane in treatment of hard-to-heal diabetic foot ulcers in complex cases: a case series.","authors":"Megan Oltmann, David Kyle, Thomas J Gilbert, Carol Devlin, R Allyn Forsyth, Sara Shahbazi","doi":"10.12968/jowc.2025.0022","DOIUrl":"https://doi.org/10.12968/jowc.2025.0022","url":null,"abstract":"<p><strong>Objective: </strong>Diabetic foot ulcers (DFUs) are a common and severe complication of diabetes, characterised by high morbidity, recurrence and risk of amputation. Hard-to-heal (chronic) DFUs often fail to respond to standard of care (SoC), necessitating advanced interventions. Lyophilised human amnion/chorion membrane (LHACM) is a trilayer placental allograft that provides extracellular matrix support, growth factors and anti-inflammatory properties to promote wound closure. This case series evaluates the effectiveness of LHACM as an adjunct to SoC in treating hard-to-heal DFUs unresponsive to conventional treatments.</p><p><strong>Method: </strong>Patients with Wagner Grade 2 or 3 DFUs (each of which had been hard-to-heal and unresponsive to SoC for 1-3 years) and multiple comorbidities were treated with LHACM following thorough wound debridement, customised dressings and offloading strategies. Wound closure, infection control and functional outcomes were assessed.</p><p><strong>Results: </strong>This was a case series of three male patients, aged 65-66 years. All wounds demonstrated significant size reduction within three weeks of treatment, achieving complete closure within a mean of 47 days (range: 35-56 days). No infection recurrences or complications were observed and patients resumed daily activities. LHACM's ease of application and compatibility with SoC facilitated integration into the treatment protocol.</p><p><strong>Conclusion: </strong>LHACM demonstrated effectiveness in accelerating wound closure in complex hard-to-heal DFUs resistant to SoC, highlighting its potential to mitigate complications, reduce healthcare costs and improve patient quality of life. Further large scale studies are warranted to confirm these findings and explore broader applications in advanced wound care.</p>","PeriodicalId":17590,"journal":{"name":"Journal of wound care","volume":"34 3","pages":"187-194"},"PeriodicalIF":1.5,"publicationDate":"2025-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143567539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Dermabond Prineo: a systematic review and meta-analysis.","authors":"Shreya Kulkarni, Matthew Goodbun, Mohammed Chowdhury, Philip W Stather","doi":"10.12968/jowc.2023.0024","DOIUrl":"https://doi.org/10.12968/jowc.2023.0024","url":null,"abstract":"<p><strong>Objective: </strong>Dermabond Prineo (Ethicon Inc., US) is a combination of a skin adhesive applied over a polyester mesh to reinforce and share tension equally over the surgical wound with the aim of reducing closure time and improving wound healing. The aims of this systematic review were to assess published data on Dermabond Prineo regarding infection rates, delayed wound healing, cosmetic appearance and application time compared to conventional wound closure techniques across multiple surgical procedures.</p><p><strong>Method: </strong>A literature search was conducted according to PRISMA guidelines. The primary outcome was the incidence of wound infection after Dermabond Prineo compared to controls, namely traditional methods of wound closure such as staples, sutures and adhesives. Secondary outcome measures included allergic reactions and time taken for application.</p><p><strong>Results: </strong>A literature search using PubMed, SCOPUS and Science Direct identified 52 studies, of which 19 were eligible for qualitative synthesis and 12 for meta-analysis. The studies included reflected a broad range of applications of Dermabond Prineo for wound closure in abdominoplasty, mammoplasty and arthroplasty. Overall, all studies reporting on time taken for application found that Dermabond Prineo reduced time for wound closure. Meta-analysis identified a statistically significant reduction in wound infection rates (Dermabond Prineo 1.51%, control 2.13%; OR: 0.65 (0.46, 0.91); p=0.01) and a reduction in delayed wound healing (Dermabond Prineo 0.99%, control 1.79%; OR: 0.42 (0.18, 0.98); p=0.05). All three studies reporting on outcomes of scar cosmesis or long-term maturation attested to improved cosmetic results compared with sutures. The cost-effectiveness of Dermabond Prineo with a hypothetical model was discussed in two studies which concluded that it could achieve savings of $50-76 USD per patient, while a retrospective model found no statistically significant difference in total hospital costs or operating room time.</p><p><strong>Conclusion: </strong>In this review, Dermabond Prineo showed lower wound infection rates and a reduction in delayed wound healing. Further studies are required to assess cost-effectiveness in a real-world setting.</p>","PeriodicalId":17590,"journal":{"name":"Journal of wound care","volume":"34 3","pages":"220-226"},"PeriodicalIF":1.5,"publicationDate":"2025-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143567541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effectiveness of an enhanced silver-containing dressing in hard-to-heal venous leg ulcers: a randomised controlled trial.","authors":"Stefania Beraldo, Jan Ljungqvist, Rebecca Rodger, Beate Hanson, Catarina Saavedra","doi":"10.12968/jowc.2025.0023","DOIUrl":"https://doi.org/10.12968/jowc.2025.0023","url":null,"abstract":"<p><strong>Objective: </strong>To assess the efficacy and safety of a carboxymethylcellulose dressing containing ionic silver, ethylenediaminetetraacetic acid and benzethonium chloride (CISEB) versus a dialkylcarbamoyl chloride-coated dressing (DACC) in hard-to-heal venous leg ulcers (VLUs).</p><p><strong>Method: </strong>In a multinational, multicentre, randomised controlled trial, patients with hard-to-heal VLUs were randomised 1:1 to receive CISEB (n=100) or DACC (n=103) for up to four weeks. VLUs that were not healed by week 4 were managed with standard of care for up to 12 weeks or until healed (whichever was sooner). The primary endpoint was complete wound closure at week 12. Additional endpoints included time to complete wound closure and incidence of adverse events (AEs).</p><p><strong>Results: </strong>The trial cohort included 203 patients. CISEB achieved a higher rate of complete wound closure by week 12 compared to DACC (74.8% versus 55.6%, respectively; p<0.0031), and was associated with a 35% increased likelihood of healing (risk ratio, 1.35; 95% confidence interval: 1.10-1.65). Median time to complete wound closure was shorter in the CISEB arm (56 days) compared to the DACC arm (70 days; p<0.0272). A smaller proportion of patients experienced an AE with CISEB compared to DACC (5.0% versus 17.6%, respectively).</p><p><strong>Conclusion: </strong>Management of hard-to-heal VLUs with CISEB was associated with improved healing outcomes compared to DACC, without additional safety concerns. CISEB is a gelling fibre dressing with antimicrobial, metal-chelating and surfactant components that may promote an optimal healing environment to address the challenge of hard-to-heal wounds.</p>","PeriodicalId":17590,"journal":{"name":"Journal of wound care","volume":"34 3","pages":"170-178"},"PeriodicalIF":1.5,"publicationDate":"2025-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143567544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Long-term patient satisfaction with their split-thickness skin graft donor site and the need for improved preoperative counselling.","authors":"Daniëlle Rijpma, Annebeth Meij-de Vries, Annika Reuvers, Tsjitske Haanstra, Paul van Zuijlen, Anouk Pijpe","doi":"10.12968/jowc.2023.0037","DOIUrl":"https://doi.org/10.12968/jowc.2023.0037","url":null,"abstract":"<p><strong>Objective: </strong>There is a lack of studies on patient-reported outcomes of split-thickness skin graft (STSG) donor sites, especially on patient satisfaction. Donor site counselling could contribute to realistic patient expectations, which could improve postoperative patient satisfaction. Therefore, this study aimed to investigate donor site counselling and patient satisfaction with the final donor site outcome.</p><p><strong>Method: </strong>Preoperative consultations were observed and given donor site information reviewed by means of a checklist. Next, a dual survey on donor site satisfaction and patient-reported donor site scar quality (measured using the patient scale of the Patient and Observer Scar Assessment Scale 3.0 adapted for this study to cover the donor site) was sent to patients who received STSG surgery 12±3 months prior to the study start. A backward linear regression analysis was used to identify potential satisfaction predictors.</p><p><strong>Results: </strong>A total of 35 preoperative consultations were observed (19 adult and 16 paediatric consultations) and 36 patients (mean age: 41 years) responded to the survey. For the adults, 'location options' was the most discussed item and 'size' was the least discussed. Of the patients, 83% were satisfied with the donor site in general and 50% were dissatisfied with postoperative complaints, such as pain or itching. Most (92%) patients experienced colour differences, which was also a negative predictor for satisfaction with donor sites in general and their appearance. Being male was a positive predictor for satisfaction with donor sites in general, size and colour differences.</p><p><strong>Conclusion: </strong>The majority of patients in the study were satisfied with their donor sites. Dissatisfaction was observed with size, appearance and postoperative complaints. Unrealistic expectations could play a role in dissatisfaction; information tools as illustrations and animations may help in managing patient expectations. Future research should focus on improvement of patient satisfaction with donor site aspects such as size and colour.</p>","PeriodicalId":17590,"journal":{"name":"Journal of wound care","volume":"34 3","pages":"228-238"},"PeriodicalIF":1.5,"publicationDate":"2025-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143567550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Use of prolonged closed suction drainage for synovial fluid-draining wounds around the ankle.","authors":"Park Hyun-Jin, You Ki-Han, Hong Seokho, Kim Hyong Nyun","doi":"10.12968/jowc.2022.0029","DOIUrl":"10.12968/jowc.2022.0029","url":null,"abstract":"<p><strong>Objective: </strong>When synovial fluid drains through a wound, cells necessary to form tissue required for healing are washed away. This results in failure of wound closure, often necessitating a pedicled or free flap reconstruction. We hypothesised that prolonged (>48 hours post surgery) closed suction drainage can reduce the fluid draining through the wound, enabling wound healing and eliminating the need for a pedicled or free flap reconstruction. We also aimed to determine whether prolonged application of closed suction drainage would increase postoperative infection.</p><p><strong>Method: </strong>A retrospective study was performed between August 2015 and December 2020. Patients with fluid-draining wounds around the ankle which had failed to respond to treatment with delayed closure and which required the use of prolonged closed suction drainage were included. Closed suction (Jackson-Pratt, JP) drainage was applied from the time of wound closure until the wound healed.</p><p><strong>Results: </strong>A total of 20 patients (12 male: eight female; mean age: 52 years; range: 21-74 years) were included in the study. The results showed the JP drain being kept for a mean of 14.1±1.8 (range: 9-16) postoperative days. Prolonged closed suction drainage helped achieve wound closure in 19 (95%) patients. Only one patient with Achilles tendon exposure underwent sural flap surgery. None of the patients developed an infection due to prolonged use of the JP drain. With regards to patient satisfaction, four (21%), 10 (53%), four (21%) and one (5%) patients were 'very satisfied', 'satisfied', 'fair' and 'dissatisfied', respectively, with the results of the treatment technique at follow-up (mean: 29.9; range: 12-72 months). The remaining patient was lost to follow-up.</p><p><strong>Conclusion: </strong>Prolonged application of closed suction drainage made wound closure possible for synovial fluid-draining wounds, eliminating the need for a pedicled or free flap surgery, without increasing the rates of wound infection. This technique could be used as an adjunct to the local flap, negative pressure wound therapy or other reconstructive techniques at the time of revision surgery.</p>","PeriodicalId":17590,"journal":{"name":"Journal of wound care","volume":"34 Sup3","pages":"xxii-xxix"},"PeriodicalIF":1.5,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143582317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}